categoriesreadsindexteamreach us
old postsbulletindiscussionshelp

2024 Year-End Market Review: Notable Gains in Stocks and Bonds

January 1, 2025 - 13:32

2024 Year-End Market Review: Notable Gains in Stocks and Bonds

As 2024 comes to a close, the US market averages, including the Dow Jones Industrial Average, Nasdaq Composite, and S&P 500, have shown impressive annual gains despite a recent dip. The Nasdaq Composite, in particular, has surged by over 28% this year, reflecting strong performance in the technology sector.

Jared Blikre, host of Market Domination Overtime, provided a comprehensive assessment of the year’s market dynamics. He noted a significant shift towards the Russell 2000 small-cap index, which has been indicative of broader economic trends and investor sentiment. Mid-year volatility, marked by fluctuations in the volatility index, added an element of unpredictability but ultimately did not overshadow the overall positive trajectory of the markets.

In addition to equities, the bond market also reached notable highs, demonstrating resilience and attracting investor interest. The year has been characterized by a complex interplay of factors influencing both stocks and bonds, setting the stage for an intriguing start to 2025.


MORE NEWS

Assessing TFS Financial (TFSL) Valuation After Second Quarter Earnings And Continued Growth In Net Income

May 7, 2026 - 02:52

Assessing TFS Financial (TFSL) Valuation After Second Quarter Earnings And Continued Growth In Net Income

TFS Financial (TFSL) reported its second quarter results, posting net interest income of US$77.81 million and net income of US$23.25 million. The company also showed modest earnings per share...

Revolution Medicines Reports First Quarter 2026 Financial Results and Update on Corporate Progress

May 6, 2026 - 19:46

Revolution Medicines Reports First Quarter 2026 Financial Results and Update on Corporate Progress

Revolution Medicines has released its financial results for the first quarter of 2026, alongside a significant update on its clinical pipeline. The company announced that its drug candidate...

Crypto’s ‘decentralised finance’ sector hit by investor exodus after hacks

May 6, 2026 - 01:18

Crypto’s ‘decentralised finance’ sector hit by investor exodus after hacks

Decentralized finance, once hailed as the revolutionary future of banking and trading, is now dealing with a serious crisis of confidence. Investors are pulling funds out at a notable rate, driven...

Neurocrine Biosciences Reports First-Quarter 2026 Financial Results

May 5, 2026 - 23:12

Neurocrine Biosciences Reports First-Quarter 2026 Financial Results

Neurocrine Biosciences released its financial report for the first quarter of 2026, covering the period ending March 31. The company disclosed its revenue and earnings figures for the three-month...

read all news
categoriesreadsindexteamreach us

Copyright © 2026 Earnge.com

Founded by: Harlan Wallace

old postssuggestionsbulletindiscussionshelp
privacycookie infouser agreement